4 completed, 3 unknown, 2 not yet recruiting, 1 recruiting. 3 Not applicable, 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Not yet recruiting 1 |
| Phase 3 | 3 | Unknown 2, Completed 1 |
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow Inosine Triphosphate: new trials by email Literature Review of Inosine Triphosphate trials Research Report on Inosine Triphosphate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Selective Mediterranean Diet in Immune Thrombocytopenia Selective Mediterranean Diet, Standard Pharmacological Therapy for ITP - Immune Thrombocytopenia, Idiopathic Thrombocytopenic Purpura | Not applicable | Not yet recruiting | Assiut University | 60 | 2026-09-01 | 2026-09-03 |
| Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on Treatment Search for thyroid disorders, Laboratory test, Steroid and eltrombopage - Immune Thrombocytopenic Purpura, Thyroid Disorders | Not yet recruiting | Assiut University | 100 | 2025-07-01 | 2025-07-17 | |
| Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer ITP and cancer - Immune Thrombocytopenia, Immune Thrombocytopenic Purpura | Completed | University Hospital, Bordeaux | 33 | 2024-08-13 | 2026-01-26 | |
| A Phase II Study of Neoadjuvant Immunotherapy in Combination With Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma Ivonescimab combined with TP, Cadonilimab combined with TP, Penpulimab combined with TP - Head and Neck Squamous Cell Carcinoma | Phase 2 | Recruiting | Lei Liu | 90 | 2024-07-01 | 2024-12-02 |
| Building Resilience in Cyberbullying Victims Wise Intervention (SA, ITP and resilience), Standard preventive intervention - Cyberbullying, Depression | Not applicable | Completed | University of Deusto | 850 | 2020-09-15 | 2021-09-28 |
| RP% Measurement by FCM as a Diagnostic Test for ITP RP% Measurement by FCM as a Diagnostic Test for ITP - Immune Thrombocytopenia | Unknown | Shandong University | 500 | 2016-11-01 | 2016-11-18 | |
| DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP Patients DEX Combined With RTX, CSA and IVIG - Immune Thrombocytopenia | Phase 3 | Unknown | Shandong University | 100 | 2016-06-01 | 2016-07-15 |
| Prevention of Lymphedema Among Breast Cancer Patients Through Implementation of an Integrative Therapy Program (ITP) ITP - Lymphedema | Not applicable | Completed | Huntington Memorial Hospital | 10 | 2013-08-01 | 2022-03-02 |
| Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia Antox tablets(Mepaco), drug therapy for ITP - Immune Thrombocytopenia | Phase 2 / Phase 3 | Unknown | Ain Shams University | 100 | 2013-03-01 | 2013-01-09 |
| Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia rhIL-11 - Purpura, Thrombocytopenic, Idiopathic | Withdrawn | Ming Hou | 2011-03-01 | 2016-04-20 | ||
| Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura Medical Standard of Care for ITP, Romiplostim - Idiopathic Thrombocytopenic Purpura, Thrombocytopenia | Phase 3 | Completed | Amgen | 234 | 2006-12-01 | 2022-11-08 |
Purpura, Thrombocytopenic, Idiopathic (8) · Thrombocytopenia (2) · Cyberbullying (1) · Depression (1) · Feeding and Eating Disorders (1) · Hematologic Diseases (1) · Hemostatic Disorders (1) · Jacobs syndrome (1) · Lymphedema (1) · Neoplasms (1) · Purpura, Thrombocytopenic (1) · Self-Injurious Behavior (1) · Squamous Cell Carcinoma of Head and Neck (1) · Thyroid Diseases (1)
Assiut University (2) · Shandong University (2) · Ain Shams University (1) · Amgen (1) · Huntington Memorial Hospital (1) · Lei Liu (1) · Ming Hou (1) · University Hospital, Bordeaux (1) · University of Deusto (1)
China (4) · Egypt (1) · France (1) · Spain (1) · United States (1)
Esther Calvete, PhD (1) · Ming Hou (1) · Ming Hou, Dr. (1) · Mohsen S Elalfy, professor (1) · Suzie S Kline, PhD (1)
PMID 20546023, PMID 25618218, PMID 26831482
2019 (1)